DEF: Everest Consolidator Seeks Extension Amid Legal Battles
Proxy Statement for Extension
Everest Consolidator Acquisition Corporation seeks stockholder approval to extend its business combination deadline to December 31, 2026, while navigating multiple lawsuits and a low stock price.
Summary
- A special meeting is scheduled for January 20, 2026, to vote on proposals to extend the company's business combination deadline to December 31, 2026.
- The proposals include amending the company's Amended and Restated Certificate of Incorporation and the Investment Management Trust Agreement.
- The company's previously entered Business Combination Agreement was terminated on October 1, 2024, and it is currently in negotiations for a new business combination, though no assurances can be given.
- Multiple lawsuits from DLA, LLC and Straten Lending Group, LLC have resulted in temporary restraining orders and preliminary injunctions, restricting distributions from the trust account and delaying redemption processes.
- Waiver and Voting Agreements have been secured with stockholders owning 2,818,079 public shares, with 563,615 redemption requests reversed, ensuring sufficient votes for the extension proposals and enabling some trust fund release despite legal holds.
- The estimated per share redemption price is approximately $12.12, significantly higher than the Class A common stock's most recent trading price of $2.00 on the OTC Markets as of December 17, 2025.
- Approval of the charter amendments requires the affirmative vote of at least 65% of the outstanding Class A and Class B common stock, which is effectively guaranteed by the combined voting power of initial stockholders (60.4%) and signing stockholders (39.4%).
Sentiment
Score: 2
Explanation: The company is facing significant operational and legal challenges, including the termination of a previous business combination, multiple lawsuits restricting trust account funds, and a stock price far below redemption value. While management is seeking an extension and is in negotiations, the overall situation is highly precarious with substantial risks of liquidation and warrant expiration.
Positives
- The Board believes the extension is in stockholders' best interest to provide more time to find and consummate a business combination.
- The company is actively engaged in negotiations with other entities to enter into a new Business Combination Agreement.
- Waiver and Voting Agreements with stockholders representing 2,818,079 public shares ensure the necessary votes for the extension proposals and facilitate the release of some trust account funds despite legal injunctions.
- The Sponsor has agreed to indemnify the company to ensure trust account proceeds are not reduced below $10.20 per share by certain third-party claims, provided specific waivers are in place.
Negatives
- The previous business combination agreement was terminated on October 1, 2024, leaving the company without a target.
- Multiple ongoing lawsuits from DLA, LLC and Straten Lending Group, LLC have led to court orders (TRO, Preliminary Injunction, Default Judgment) that restrict trust account funds and have delayed redemption processes.
- A default judgment of $2,955,343 against the company and its Sponsor in favor of Straten remains in effect.
- The market price of Class A common stock ($2.00 as of December 17, 2025) is substantially below the estimated redemption price ($12.12), indicating significant market skepticism.
- The company's public shares are deemed 'penny stock,' which may adversely affect liquidity and trading.
- The proposed extension contradicts the company's original Amended and Restated Certificate of Incorporation and Trust Agreement, potentially exposing the Board to shareholder lawsuits.
- The Sponsor's ability to satisfy its indemnity obligations is uncertain, as its only assets are believed to be company securities.
- A 1% U.S. federal excise tax may be imposed on redemptions, which will not be paid from the trust account.
Risks
- There is no assurance that the extension will enable the company to complete a business combination by the Extended Date.
- Redemptions by public stockholders could significantly reduce the trust account balance, potentially leaving insufficient cash or public float to consummate a business combination on commercially acceptable terms.
- The company risks being deemed an unregistered investment company, which could force liquidation and render warrants worthless.
- Holding funds in an interest-bearing demand deposit account (to mitigate investment company risk) may result in less interest earned, reducing the dollar amount public stockholders receive upon redemption or liquidation.
- The company's ability to complete an initial business combination with a U.S. target may be impacted by U.S. foreign investment regulations and review by CFIUS, potentially leading to delays or prohibition.
- The classification of public shares as 'penny stock' may adversely affect their liquidity and trading, making it difficult for stockholders to sell shares in the open market.
- The DLA and Straten litigations may delay the redemption process for public shares.
- The proposed extension contradicts the company's original charter and trust agreement, potentially exposing the Board to shareholder opposition or lawsuits for breaching fiduciary duties.
Future Outlook
The company is actively negotiating with other entities to enter into a new Business Combination Agreement and aims to complete a business combination by the extended date of December 31, 2026. However, there are no assurances that a new agreement will be reached or that a business combination will be completed within the extended timeframe.
Management Comments
- The Board of Directors unanimously recommends a vote FOR the Extension Amendment Proposal, the Trust Amendment Proposal and, if presented, the Adjournment Proposal.
- The Board believes that the Extension is necessary in order to be able to consummate a business combination.
- The Board has determined that it is in the best interests of our stockholders to extend the date by which the Company must consummate a business combination to the Extended Date in order to provide our stockholders with the opportunity to participate in the prospective investment.
- The company and its advisors required additional time to update the disclosure, evaluate strategic alternatives, and finalize the terms of the proposals being presented to stockholders, as well as to evaluate the effects of the TRO, Preliminary Injunction and the litigation filed by Straten.
- The company determined that it was in the best interests of the Company and its stockholders to file the proxy statement only after this process was complete.
- The company believes that given the company's expenditure of time, effort and money on searching for potential business combination opportunities, including the fact that we are in active discussions regarding a business combination, circumstances warrant providing public stockholders an opportunity to consider a business combination.
- Our Board recommends that you vote in favor of the Extension Amendment Proposal, but expresses no opinion as to whether you should redeem your public shares.
Industry Context
This filing reflects the ongoing challenges faced by Special Purpose Acquisition Companies (SPACs) in the current market, particularly the difficulty in identifying and consummating suitable business combinations within initial deadlines. The need for multiple extensions and the presence of significant litigation highlight the increased scrutiny and operational complexities in the SPAC sector. The low trading price relative to the redemption value also indicates a broader market sentiment of skepticism towards SPACs that have not yet completed a de-SPAC transaction.
Comparison to Industry Standards
- NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Charter Amendment | Proposal to amend the Amended and Restated Certificate of Incorporation to extend the date by which the company must consummate a business combination to December 31, 2026. | Upon stockholder approval and filing with the Delaware Secretary of State | Extends the company's corporate existence, providing additional time to secure a business combination, but also prolongs uncertainty and the potential for further redemptions, which could reduce the trust account balance. |
| Trust Agreement Amendment | Proposal to amend the Investment Management Trust Agreement to extend the Combination Period to December 31, 2026. | Upon stockholder approval and execution of the amendment | Aligns the trust agreement with the extended corporate existence, allowing funds to remain in the trust account for a longer period, subject to existing legal holds and potential future redemptions. |
Legal Proceedings
- DLA, LLC filed a lawsuit against the Trustee on October 29, 2024, for approximately $3 million in unpaid accounting fees. A Temporary Restraining Order (TRO) was entered on November 1, 2024, restraining trust account distributions below this amount.
- DLA, LLC filed a separate lawsuit against the Company and its Sponsor in New Jersey on November 20, 2024, for allegedly owed fees. A Preliminary Injunction was granted on December 3, 2024. A default judgment was vacated on December 4, 2025, and the case remains pending.
- Straten Lending Group, LLC filed a lawsuit against the Company and its Sponsor in Delaware on November 27, 2024, related to two senior note term sheets. A Default Judgment of $2,955,343 was entered on February 19, 2025, and remains in effect after a motion to vacate was denied on procedural grounds on November 7, 2025.
- Straten Lending Group, LLC filed another lawsuit against the Company and its Sponsor in New York on July 25, 2025, seeking a New York judgment based on the Delaware Default Judgment. Cross-motions are currently pending resolution.
Related Party Transactions
- The Sponsor paid $18,750 for 4,312,500 founder shares.
- The Sponsor purchased 6,333,333 private placement warrants for $9,500,000.
- The Sponsor, officers, and directors have agreed to waive their redemption rights with respect to their founder shares and public shares.
- The Sponsor has agreed to indemnify the company for certain third-party claims against the trust account, though its ability to satisfy these obligations is uncertain as its only assets are believed to be company securities.
- The Sponsor, officers, or directors, or their affiliates may be reimbursed for out-of-pocket expenses incurred on the company's behalf related to identifying, investigating, negotiating, and completing a business combination (no outstanding expenses as of the filing date).
Stakeholder Impact
- **Shareholders**: Public stockholders have the option to redeem shares at an estimated $12.12, significantly higher than the current market price of $2.00, but redemptions may be delayed by ongoing litigation. Those who do not redeem face prolonged uncertainty and the risk of warrants expiring worthless if no business combination is completed.
- **Warrant Holders**: Warrants will expire worthless if the company liquidates, which is a significant risk given the current operational and legal challenges.
- **Creditors**: The company has obligations under Delaware law to provide for claims of creditors in case of liquidation. Legal proceedings by DLA and Straten directly impact the trust account, which is primarily intended for public stockholder redemptions.
- **Management/Sponsor**: The Sponsor and management stand to lose their entire investment in founder shares and private placement warrants if a business combination is not completed, creating a strong incentive to complete a deal, potentially even on less favorable terms.
Next Steps
- Hold a Special Meeting on January 20, 2026, to vote on the Extension Amendment Proposal, Trust Amendment Proposal, and Adjournment Proposal.
- If the Extension Amendment Proposal is approved, file an amendment to the charter with the Secretary of State of Delaware.
- If the Trust Amendment Proposal is approved, enter into the proposed Trust Amendment.
- Continue efforts to consummate a business combination by the Extended Date of December 31, 2026.
- If the Extension Amendment Proposal is not approved, cease operations, redeem 100% of outstanding public shares, and dissolve and liquidate.
- Continue vigorously defending against the DLA and Straten lawsuits and pursuing available legal remedies.
Key Dates
| Date | Description |
|---|---|
| March 8, 2021 | Company incorporated. |
| November 23, 2021 | Investment Management Trust Agreement dated. |
| November 29, 2021 | Consummation of Initial Public Offering (IPO). |
| August 24, 2023 | Stockholders approved the First Extension Amendment. |
| February 8, 2024 | Schedule 13G/A filed by Saba Capital Management, L.P. |
| February 26, 2024 | Stockholders approved the Second Extension Amendment. |
| April 16, 2024 | Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC. |
| August 28, 2024 | Stockholders approved the Third Extension Amendment. |
| September 5, 2024 | Schedule 13G/A filed by Wolverine Asset Management, LLC. |
| October 1, 2024 | Termination of previously entered Business Combination Agreement with Unifund Holdings, LLC. |
| October 29, 2024 | DLA, LLC filed a lawsuit against the Trustee for unpaid accounting fees. |
| November 1, 2024 | New York court entered a Temporary Restraining Order (TRO) against the Trust Account in the DLA lawsuit. |
| November 20, 2024 | DLA, LLC filed a lawsuit against the Company and its Sponsor in New Jersey. |
| November 22, 2024 | Stockholder meeting approved a previous extension. |
| November 23, 2024 | Original Combination Period end date. |
| November 27, 2024 | Straten Lending Group, LLC filed a lawsuit against the Company and its Sponsor in Delaware. |
| December 3, 2024 | New Jersey court granted a Preliminary Injunction in the DLA lawsuit. |
| February 19, 2025 | Delaware court entered a Default Judgment of $2,955,343 against the Company and its Sponsor in the Straten lawsuit. |
| April 4, 2025 | Schedule 13G/A filed by Calamos Market Neutral Income Fund. |
| July 25, 2025 | Straten filed a lawsuit against the Company and its Sponsor in New York, seeking summary judgment based on the Delaware Default Judgment. |
| August 20, 2025 | Straten, the Company, and Sponsor agreed to extend the deadline to respond to the Motion for Summary Judgment until August 29, 2025. |
| August 29, 2025 | Company and Sponsor moved to vacate the Default Judgment in Delaware and dismiss the Motion for Summary Judgment in New York. |
| September 18, 2025 | Parties filed a stipulation requesting adjournment of cross-motions until after the Delaware Court ruled on the motion to vacate the Default Judgment. |
| September 22, 2025 | New York Court granted the stipulation, holding cross-motions in abeyance. |
| November 7, 2025 | Delaware Court of Chancery denied the motion to vacate the Default Judgment on procedural grounds. |
| November 14, 2025 | Straten advised the New York Court that the motion to vacate had been denied by the Delaware Court. |
| December 4, 2025 | New Jersey court denied DLA's motion for final judgment by default and granted the Company's and Sponsor's motion to vacate the default. |
| December 17, 2025 | Most recent trading price of Class A common stock ($2.00) and warrants ($.011) on OTC Markets. |
| December 18, 2025 | Record date for determining stockholders entitled to vote at the special meeting. |
| January 6, 2026 | Date of the Proxy Statement. |
| January 13, 2026 | Deadline for timely delivery of documents in advance of the special meeting (5:00 p.m. Eastern Time). |
| January 16, 2026 | Deadline for redemption requests (5:00 p.m. Eastern Time, two business days prior to the special meeting). |
| January 20, 2026 | Date of the Special Meeting (4:15 PM Eastern Time). |
| December 31, 2026 | Proposed Extended Date for the company to consummate a business combination. |
Recommendation
sellGiven the termination of a prior business combination, multiple ongoing lawsuits that have frozen trust account funds and delayed redemptions, and the significant discount of the market price ($2.00) to the estimated redemption value ($12.12), the risk of further delays, potential liquidation, and warrants expiring worthless is extremely high. While the extension provides more time, the fundamental issues and legal entanglements create an unfavorable risk-reward profile. Investors should consider redeeming their shares if possible, or selling in the open market if the redemption process is too uncertain, to minimize further capital erosion.
Keywords
SPAC, Everest Consolidator Acquisition Corporation, Business Combination, Extension, Proxy Statement, Redemption Rights, Trust Account, SEC Filing, Corporate Governance, Litigation, DLA LLC, Straten Lending Group, Special Meeting, Shareholder Vote, DEF 14A, Investment Company Act, Penny Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.